ghk-cu interaction with cjc-1295 ipamorelin + CJC-1295 vs Ipamorelin: The Ultimate

References Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al

Genome Biol

AOD9604 in Duluth Embarking on a transformative journey towards a healthier, more vibrant you

Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy

Clinicians should not present DSIP benefits whether framed as DSIP for sleep or otherwise as proven, and should be candid about the wide gap between early signals and clinical proof